Blog

In the wake of a recent multi-state meningitis outbreak that has left five people dead and another 35 hospitalized, regulatory officials are concerned that the fungal infection could continue to spread at an alarming rate. Collaborative efforts by both the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration…

GNC Says “No Basis” for FDA Crackdown on DMAA Supplements. Read our informative blog to learn more about personal injury, defective products and sexual abuse cases.

Regarded as an upgrade to its predecessor, Reumofan Plus, Reumofan Plus Premium is intended to provide 24 hour joint and muscle pain relief for those suffering from degenerative bone conditions such as arthritis and osteoporosis. Unfortunately, however, a lab analysis conducted by the U.S. Food and Drug Administration (FDA) revealed the presence of two…

Amidst the relentless scrutiny that has already shrouded Actos for its association with bladder cancer, growing concerns regarding yet another catastrophic side effect continue to plague Takeda Pharmaceuticals. Recent studies preformed by researchers at the University of Nottingham suggest that Actos may be responsible for individuals developing macular edema, a condition in which symptoms…

While fourth generation contraceptives have proven to be capable in assisting in the prevention of pregnancy, prolonged use has recently become a subject of great concern. Subsequently, recent studies lend weight to the long-suspected link between drospirenone-containing contraceptives and the development of life-threatening blood clots. In response to these findings, the U.S. Food and…

Recent evidence suggests that the long-suspected link between popular selective serotonin reuptake inhibitors (SSRI’s), like Paxil and Prozac, and congenital heart birth defects is more relevant than ever before. According to Finnish researchers, who published their findings in Obstetrics & Gynecology medical journal; when pregnant women use the antidepressants Prozac and Paxil, they can…

Following a licensing and supply agreement by Bayer Healthcare, select drug manufacturers are now able to develop and market their own variation of generic Yasmin (drospirenone and ethinyl estradiol) products despite the existing patent. Similar to that of Yasmin, generic birth control variations introduced by Barr and Teva are indicated to assist in the…

The U.S. Food and Drug Administration (FDA) has recently been made aware of the potentially fatal side effects associated with a trending multiple sclerosis medication. Subsequently, officials at the FDA received a report of a patient with multiple sclerosis who died within 24 hours of taking their first dose of Gilenya (generic: fingolimod). Upon…